Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $418.20 | Total: $2,091.00 |
| 1 | 10 | $354.24 | Total: $3,542.40 |
| 1 | 25 | $300.12 | Total: $7,503.00 |
| 1 | 50 | $255.84 | Total: $12,792.00 |
| 1 | 100 | $221.40 | Total: $22,140.01 |
Overview
UCB7362 (GLXC-26743) is an orally available and potent plasmepsin X (PMX) inhibitor with anti-malarial activity.UCB7362 inhibits parasite reproduction.
Chemical Properties
| Molecular Formula | C25H26ClN5O3 |
| Molecular Weight | 479.96 |
| CAS Numbers | 2610631-17-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C[C@]1(CC(=O)N(C(N)=N1)[C@H]2C[C@@H](C)OCC2)C3=C(Cl)C(NC(=O)C4=CC(C#N)=CC=C4)=CC=C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Lowe MA, et al. Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362. J Med Chem. 2022 Oct 10.